Cancer risk in patients with diverticular disease: A nationwide cohort study
- 6 October 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 115 (1) , 62-70
Abstract
Background: There are little data on diverticular disease and cancer development other than colorectal cancer. Methods: We conducted a population-based, matched cohort study with linkage of nationwide registers to the Epidemiology Strengthened by histoPathology Reports in Sweden histopathology cohort. We included 75 704 patients with a diagnosis of diverticular disease and colorectal histopathology and 313 480 reference individuals from the general population matched on age, sex, calendar year, and county. Cox proportional hazards models estimated multivariable-adjusted hazard ratios (HRs) for associations between diverticular disease and overall cancer and specific cancers. Results: Over a median follow-up of 6 years, we documented 12 846 incident cancers among patients with diverticular disease and 43 354 incident cancers among reference individuals from the general population. Compared with reference individuals, patients with diverticular disease had statistically significantly increased overall cancer incidence (24.5 vs 18.1 per 1000 person-years), equivalent to 1 extra cancer case in 16 individuals with diverticular disease followed-up for 10 years. After adjusting for covariates, having a diagnosis of diverticular disease was associated with a 33% increased risk of overall cancer (95% confidence interval [CI] = 1.31 to 1.36). The risk increases also persisted compared with siblings as secondary comparators (HR = 1.26, 95% CI = 1.21 to 1.32). Patients with diverticular disease also had an increased risk of specific cancers, including colon cancer (HR = 1.71, 95% CI = 1.60 to 1.82), liver cancer (HR = 1.72, 95% CI = 1.41 to 2.10), pancreatic cancer (HR = 1.62, 95% CI = 1.42 to 1.84), and lung cancer (HR = 1.50, 95% CI = 1.39 to 1.61). The increase in colorectal cancer risk was primarily restricted to the first year of follow-up, and especially early cancer stages. Conclusions: Patients with diverticular disease who have colorectal histopathology have an increased risk of overall incident cancer.Keywords
Funding Information
- Swedish Cancer Foundation
- MGH Executive Committee on Research Tosteson
- Fund for Medical Discovery Postdoctoral Fellowship Award and American Gastroenterological Association Research Scholar Award (AGA2021-13-01)
- National Institutes of Health (R01 DK101495)
- Stuart and Suzanne Steele MGH Research Scholar Award
This publication has 33 references indexed in Scilit:
- Colorectal-Cancer Incidence and Mortality with Screening Flexible SigmoidoscopyNew England Journal of Medicine, 2012
- Lifestyle Factors and the Course of Diverticular DiseaseDigestive Diseases, 2012
- Diverticular disease and the risk of colon cancer - a population-based case-control studyAlimentary Pharmacology & Therapeutics, 2011
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Predictive Value of Serologic Markers of Degree of Histologic Damage in Acute Uncomplicated Colonic DiverticulitisJournal of Clinical Gastroenterology, 2010
- Positive predictive values of the International Classification of Disease, 10th edition diagnoses codes for diverticular disease in the Danish National Registry of PatientsClinical and Experimental Gastroenterology, 2010
- Burden of Digestive Diseases in the United States Part II: Lower Gastrointestinal DiseasesGastroenterology, 2009
- The completeness of the Swedish Cancer Register – a sample survey for year 1998Acta Oncologica, 2009
- Body Mass Index and Diverticular Disease: A 28-Year Follow-Up Study in MenDiseases of the Colon & Rectum, 2008
- Inflammation and cancerNature, 2002